Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia
- 1 May 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (11) , 1282-1286
- https://doi.org/10.1016/0002-9149(85)90489-8
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.Circulation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Reduction of Serum Cholesterol in Heterozygous Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1983
- Familial Type II Hyperlipoproteinemia with Coronary Heart DiseaseChest, 1981
- COLESTIPOL PLUS NICOTINIC ACID IN TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1981
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Plasma lipid concentrations and lecithin:cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipolMetabolism, 1981
- Probability of Middle-Aged Men Developing Coronary Heart Disease in Five YearsCirculation, 1972
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971